Australia: Inside track: Healthcare - In the media, reports and legislation

Last Updated: 19 July 2019
Most Read Contributor in Australia, August 2019

In the media

Safety review of baby bouncers, rockers and inclined sleep products
The ACCC will begin a safety review of products designed for infants such as bouncers, rockers and inclined sleep products (12 July 2019). More...

World update recognises emotional key to healthy workplaces
In its recent 11th Revision of the International Classification of Diseases, The World Health Organisation recognised the serious effects of burnout, defining it as a syndrome resulting from chronic workplace stress that has not been successfully managed (12 July 2019). More...

TGA opioid RUM push
Pain patients with unused opioids are being urged to return them to their local pharmacy, as part of a social media campaign being rolled out by the Therapeutic Goods Administration (12 July 2019). More...

SHPA welcomes ongoing urgency to address opioid-related harm
Eight months after the release of its landmark Reducing Opioid-related Harm report, the SHPA has welcomed a new awareness campaign from the Therapeutic Goods Administration aimed at curbing the growing incidence of harm caused by opioid-containing products in the Australian community (10 July 2019). More...

'Public's not adequately protected': Medical regulator accused of not doing its job properly
Understaffing, a toxic culture and pressure to meet unrealistic targets at the national health regulator are risking public safety, according to whistleblowers (09 July 2019). More...

CEO of ARPANSA restricts production in the ANSTO Nuclear Medicine facility after accident
Production of nuclear medicine at ANSTO's Nuclear Medicine facility was halted on 21 June following an accident in which the hands of three workers were exposed to radiation (08 July 2019). More...

The deadly perils of not investing in medical AI
Professor Enrico Coiera, The Director of the Australian Institute of Health Informatics, said we were going to need to formulate a national approach to AI in medicine if we wanted our local sector to be safe and have ethical governance. In Australia, there are few standards to oversee safe and effective use of digital health, and none specifically dealing with AI (08 July 2019). More...

Child immunisation at record levels
The number of Australian children who are fully immunised continues to increase to record levels with new data showing more parents are getting the message to protect their children with life-saving vaccines (08 July 2019). More...


Aged-care home shutdown 'wake up call'
Aged-care facilities across Australia are at "risk of failure" without adequate federal funding, the industry's peak body has warned, after the sudden shut down of a Queensland facility left residents stranded. The federal government has promised a full investigation into the Queensland facility (13 July 2019). More...

Gold Coast nursing home residents in limbo, claims wages unpaid for a month
Queensland Health Minister Steven Miles has called for an investigation into the sudden closure of a Gold Coast aged care facility yesterday after claims the nursing home was stripped and patient records taken (12 July 2019). More...

Mining bosses could face $10m fines under industrial manslaughter laws
The Queensland government will consider expanding industrial manslaughter laws to the resources sector, which could lead to mining bosses being fined up to $10 million. The development comes after crisis talks on Wednesday afternoon with the mining sector, following the deaths of six workers in Queensland's mines and quarries in the past 12 months (10 July 2019). More...

Community consultation opens on CQ rehab site
The Central Queensland community will be able to have their say on a possible site for a new 42-bed residential rehabilitation site in Rockhampton (10 July 2019). More...

Superbug risk will rise if Queensland pharmacy trial continues
The Queensland government is exposing the community to one of the biggest global health risks, antibiotic resistant infections, as it prepares for a pharmacist antibiotic dispensing trial according to Queensland Chair of the RACGP, Dr Bruce Willett (08 July 2019). More...

Queensland Health issues measles alert for Brisbane's north
A measles alert has been issued for Brisbane's northside, making it the fourth in 2019. About 30 per cent of adults with measles will be hospitalised and Queensland Health offers free vaccines to anyone who was born in 1966 or later and who has not had two doses of the MMR vaccine (08 July 2019). More...

Published – articles, papers, reports

AAMRI e-news 9 July 2019
In this issue; Government update – Consultations currently open, Sector news – Government accepts stillbirth report recommendations, NHMRC update – Application dates for major schemes, MRFF update – Genomics Health Futures Missions deadline extension, Other funding & award opportunities – 2020 CSL Centenary Fellowship closes soon, Reports & resources – 2019 Sector Competitiveness Plan. More...

Practice and Regulation

RACGP Submission: Feedback on the Draft Clinical Practice Guidelines for Keratinocyte Cancer
The submission provides feedback regarding a number of areas, including the following: The title of the guidelines, Definition of the term "specialist", Epidemiology of basal cell carcinoma and Early detection of keratinocyte cancers and opportunistic screening (08 July 2019). More...

SafeWork Australia: Proposal to adopt updated GHS under the model WHS laws
Since 1 January 2017, the 3rd revised edition of the GHS (GHS 3) has been implemented under the model Work Health and Safety laws. A Consultation Paper has been prepared which outlines the key changes between GHS 3 and GHS 7 and the particular issues we would like feedback on. More...

Personalised Medical Devices
The International Medical Device Regulators Forum working group on Personalized Medical Devices is developing guidance for definitions and regulatory pathways for Regulatory Authorities to consider in the regulation of medical devices that are intended for individual patients. The goal is to promote global harmonisation in the terminology and premarket requirements for such devices. The working group's chair is Dr Elizabeth McGrath. More...

Consultation Paper on the Pricing Framework for Australian Public Hospital Services 2020–21
The Independent Health Pricing Authority is currently consulting on the Pricing Framework for Public Hospitals to apply for 2020-21. Among the matters on which the IHPA is consulting is whether it should make the National Benchmarking Portal publicly available. More...

New Australian Standards

DR AS/NZS 2500:2019
Guide to the safe use of electricity in patient care. Standards Australia. More...

TGA Notifications

Updates to variations to prescription medicines guidance and e-form
What has been updated? (10 July 2019). More...

Everything you ever wanted to know about sunscreens (but were afraid to ask)
Tips on what to consider when choosing or applying a sunscreen (10 July 2019). More...

Scheduling committees meeting dates and decisions timeframes
Scheduling committees meeting dates and decisions timeframes (10 July 2019). More...

Variations to prescription medicines - excluding variations requiring the evaluation of clinical or bioequivalence data
Updates to the prescription medicine variations guidance and e-form (10 July 2019). More...

TGA strengthens regulation of stem cell treatments
New regulations for stem cell treatments in Australia came into force on 1 July 2019 (09 July 2019). More...

Submissions received and summary: Proposal for the regulation of IVD companion diagnostics
Publication of submissions received to the 'Proposal for the regulation of IVD companion diagnostics' consultation (09 July 2019). More...

Australian Public Assessment Reports for prescription medicines (AusPARs)
Added Plitidepsin (Aplidin), Octocog alfa (bhk) (Kovaltry) and Lenalidomide (Revlimid) (08 July 2019). More...


Queensland Parliament – 11 July 2019
Report - No. 32, 56th Parliament - Medicines and Poisons Bill 2019
The Committee's findings from its investigation into the Medicines and Poisons Bill 2019.
State Development, Natural Resources and Agricultural Industry Development Committee - Report No. 32, 56th Parliament - Medicines and Poisons Bill 2019 inquiry.
Report - No. 31, 56th Parliament - Therapeutic Goods Bill 2019
The Committee's findings from its investigation into the Therapeutic Goods Bill 2019.
State Development, Natural Resources and Agricultural Industry Development Committee - Report No. 31, 56th Parliament - Therapeutic Goods Bill 2019 inquiry.

QAO Audit: Addressing mine dust lung disease
This audit will examine how effectively public sector entities have implemented recommendations aimed at reducing the risk and occurrence of mine dust lung disease. In progress. Anticipated tabling: Aug–Oct 2019. More...

HQCC Investigation register
The nature of the matter being investigated is noted below in general terms, and may be connected to relevant legislation or a framework. Descriptions beginning with a number refer to a potential offence under the corresponding section of the Health Ombudsman Act 2013. Descriptions beginning with 'Clause' refer to alleged contravention of the corresponding clause of the National Code of Conduct for Health Care Workers (Queensland). More...




Australian Hearing Services (Declared Hearing Services) Determination 2019
This instrument establishes, under the Australian Hearing Services Act 1991, the classes of people to whom Australian Hearing Services provides declared hearing services (10 July 2019).

Australia New Zealand Food Standards Code—Schedule 20–maximum residue limits Variation Instrument No. APVMA 4, 2019
This instrument amends Australia New Zealand Food Standards Code – Schedule 20 – Maximum residue limits to set new and varied maximum residue limits and make changes to certain residue definitions, commodities and substances (10 July 2019).

Hearing Services Program (Voucher) Instrument 2019
This instrument facilitates the administration of the voucher component of the Hearing Services Program as established by the Hearing Services Administration Act 1997. It determines classes of eligible persons additional to those described by the Act, the rules around obtaining and using a 'voucher' for government funded hearing services and specifies services and devices available to eligible persons (09 July 2019).

Therapeutic Goods (Breast Implants Information) Specification 2019
This instrument specifies the publication of certain therapeutic goods information relating to breast implants, mammary implants or tissue expanders (09 July 2019).

This publication does not deal with every important topic or change in law and is not intended to be relied upon as a substitute for legal or other advice that may be relevant to the reader's specific circumstances. If you have found this publication of interest and would like to know more or wish to obtain legal advice relevant to your circumstances please contact one of the named individuals listed.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions